Your browser doesn't support javascript.
loading
Methodological aspects of the molecular and histological study of prostate cancer: focus on PTEN.
Ugalde-Olano, Aitziber; Egia, Ainara; Fernández-Ruiz, Sonia; Loizaga-Iriarte, Ana; Zuñiga-García, Patricia; Garcia, Stephane; Royo, Félix; Lacasa-Viscasillas, Isabel; Castro, Erika; Cortazar, Ana R; Zabala-Letona, Amaia; Martín-Martín, Natalia; Arruabarrena-Aristorena, Amaia; Torrano-Moya, Verónica; Valcárcel-Jiménez, Lorea; Sánchez-Mosquera, Pilar; Caro-Maldonado, Alfredo; González-Tampan, Jorge; Cachi-Fuentes, Guido; Bilbao, Elena; Montero, Rocío; Fernández, Sara; Arrieta, Edurne; Zorroza, Kerman; Castillo-Martín, Mireia; Serra, Violeta; Salazar, Eider; Macías-Cámara, Nuria; Tabernero, Jose; Baselga, Jose; Cordón-Cardo, Carlos; Aransay, Ana M; Villar, Amaia Del; Iovanna, Juan L; Falcón-Pérez, Juan M; Unda, Miguel; Bilbao, Roberto; Carracedo, Arkaitz.
Afiliação
  • Ugalde-Olano A; Department of Pathology, Basurto University Hospital, 48013 Bilbao, Spain.
  • Egia A; Basque Biobank, Basque Foundation for Health Innovation and Research-BIOEF, Barakaldo, Spain.
  • Fernández-Ruiz S; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain.
  • Loizaga-Iriarte A; Department of Urology, Basurto University Hospital, 48013 Bilbao, Spain.
  • Zuñiga-García P; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain.
  • Garcia S; Centre de Recherche en Carcérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France.
  • Royo F; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), Spain.
  • Lacasa-Viscasillas I; Department of Urology, Basurto University Hospital, 48013 Bilbao, Spain.
  • Castro E; Basque Biobank, Basque Foundation for Health Innovation and Research-BIOEF, Barakaldo, Spain.
  • Cortazar AR; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain.
  • Zabala-Letona A; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain.
  • Martín-Martín N; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain.
  • Arruabarrena-Aristorena A; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain.
  • Torrano-Moya V; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain.
  • Valcárcel-Jiménez L; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain.
  • Sánchez-Mosquera P; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain.
  • Caro-Maldonado A; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain.
  • González-Tampan J; Department of Urology, Basurto University Hospital, 48013 Bilbao, Spain.
  • Cachi-Fuentes G; Department of Urology, Basurto University Hospital, 48013 Bilbao, Spain.
  • Bilbao E; Department of Urology, Basurto University Hospital, 48013 Bilbao, Spain.
  • Montero R; Department of Urology, Basurto University Hospital, 48013 Bilbao, Spain.
  • Fernández S; Department of Pathology, Basurto University Hospital, 48013 Bilbao, Spain; Basque Biobank, Basque Foundation for Health Innovation and Research-BIOEF, Barakaldo, Spain.
  • Arrieta E; Basque Biobank, Basque Foundation for Health Innovation and Research-BIOEF, Barakaldo, Spain.
  • Zorroza K; Basque Biobank, Basque Foundation for Health Innovation and Research-BIOEF, Barakaldo, Spain.
  • Castillo-Martín M; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Serra V; Molecular Therapeutics Research Unit, Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Experimental Therapeutics Group, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Salazar E; Basque Biobank, Basque Foundation for Health Innovation and Research-BIOEF, Barakaldo, Spain.
  • Macías-Cámara N; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain.
  • Tabernero J; Molecular Therapeutics Research Unit, Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Experimental Therapeutics Group, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Baselga J; Molecular Therapeutics Research Unit, Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Experimental Therapeutics Group, Vall d'Hebron University Hospital, Barcelona, Spain; Human Oncology & Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, N
  • Cordón-Cardo C; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Aransay AM; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), Spain.
  • Villar AD; Basque Biobank, Basque Foundation for Health Innovation and Research-BIOEF, Barakaldo, Spain.
  • Iovanna JL; Centre de Recherche en Carcérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France.
  • Falcón-Pérez JM; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), Spain; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
  • Unda M; Department of Urology, Basurto University Hospital, 48013 Bilbao, Spain.
  • Bilbao R; Basque Biobank, Basque Foundation for Health Innovation and Research-BIOEF, Barakaldo, Spain.
  • Carracedo A; CIC bioGUNE, Bizkaia Technology Park, 801 Building, 48160 Derio, Spain; Ikerbasque, Basque Foundation for Science, Bilbao, Spain; Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), Bilbao, Spain. Electronic address: acarracedo@cicbiogune.es.
Methods ; 77-78: 25-30, 2015 May.
Article em En | MEDLINE | ID: mdl-25697760

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Proteínas Supressoras de Tumor / PTEN Fosfo-Hidrolase Limite: Animals / Humans / Male Idioma: En Revista: Methods Assunto da revista: BIOQUIMICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Proteínas Supressoras de Tumor / PTEN Fosfo-Hidrolase Limite: Animals / Humans / Male Idioma: En Revista: Methods Assunto da revista: BIOQUIMICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha